Akers Biosciences Announces A Leadership Change Strategic Update Legal Settlement And An Aim Update | Latest News RSS feed

Akers Biosciences Announces A Leadership Change Strategic Update Legal Settlement And An Aim Update - Latest News


Akers Biosciences Announces a Leadership Change, Strategic Update, Legal Settlement and an AIM Update

Howard R. Yeaton has been appointed to the position of Chief Executive Officer effective immediately. Mr. Yeaton’s role of Chief Executive Officer is not a board position although he will work very cl... read more

Senzagen Aims At Reaching Break-Even In 2021

Oct 8 (Reuters) - Akers Biosciences Inc ::ANNOUNCES A LEADERSHIP CHANGE, STRATEGIC UPDATE, LEGAL SETTLEMENT AND AN AIM UPDATE.SAYS HOWARD R. YEATON HAS BEEN APPOINTED TO POSITION OF CHIEF EXECUTIVE OF... read more

Directorate Change & Other Information

Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), ("Akers Bio" or the "Company"), a developer of rapid health information technologies, announces a leadership change, an update to the Company's bus... read more

Looking for another news?


Akers Biosciences Announces Q2 and H1 2018 Earnings

THOROFARE, N.J., Aug. 14, 2018 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), (“Akers Bio” or the "Company"), a developer of rapid health information technologies, reports it... read more


Akers Biosciences Inc Cash from Operations (TTM):

An item on a company's cash flow statement. Lists aggregate change in cash position resulting from operations. Includes the company's cash inflows and outflows from the company's core business operati... read more

Paternoster Resources hooks investors as it unveils bid to reduce costs

Natural resource investor Paternoster Resources plc (LON:PRS) shares zipped up over 10% to 0.155p as it issued a strategic update. It reckons its corporate ... across an expanded 3.6 kilometres. Akers ... read more

E. I. du Pont de Nemours' (DD) CEO Ellen Kullman on Q2 2014 Results - Earnings Call Transcript

We will continue to make strategic investments in research, application development and customer facing resources to drive future growth. Operating margins are expected to continue the trend of year-o... read more

Horizon Discovery : Acquisition and Proposed Placing to Raise £80m

The Company also announces that it will ... established thereunder or the AIM Rules or other applicable legislation or regulation, none of the Company, the Directors, Numis nor Cowen undertakes any ob... read more

Akers Biosciences announces a leadership change and a strategic update

Akers Biosciences (NASDAQ:AKER) announces a leadership change, an update to the Company’s business strategy, the settlement of its ... London Stock Exchange’s AIM market. read more

PureTech Health plc - Half-Year Report

The Consolidated Group also further strengthened its leadership with the additions of Joep Muijrers ... In the July 2018 post-period, Vedanta Biosciences announced a financial award from the Crohn's & ... read more



FeedsRSS Created by. Full RSS Feed | Privacy Policy | Contact Us